ATE225168T1 - Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen - Google Patents

Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen

Info

Publication number
ATE225168T1
ATE225168T1 AT93203295T AT93203295T ATE225168T1 AT E225168 T1 ATE225168 T1 AT E225168T1 AT 93203295 T AT93203295 T AT 93203295T AT 93203295 T AT93203295 T AT 93203295T AT E225168 T1 ATE225168 T1 AT E225168T1
Authority
AT
Austria
Prior art keywords
cancer cells
lycopen
cell activity
pharmaceutical preparations
reduce cell
Prior art date
Application number
AT93203295T
Other languages
English (en)
Inventor
Joseph Levy
Yoav Sharoni
Original Assignee
Lycored Natural Prod Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11064278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE225168(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lycored Natural Prod Ind Ltd filed Critical Lycored Natural Prod Ind Ltd
Application granted granted Critical
Publication of ATE225168T1 publication Critical patent/ATE225168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93203295T 1992-11-30 1993-11-25 Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen ATE225168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10392092A IL103920A (en) 1992-11-30 1992-11-30 Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE225168T1 true ATE225168T1 (de) 2002-10-15

Family

ID=11064278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93203295T ATE225168T1 (de) 1992-11-30 1993-11-25 Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen

Country Status (14)

Country Link
US (1) US5827900A (de)
EP (1) EP0600544B1 (de)
JP (1) JPH06227970A (de)
KR (1) KR100301682B1 (de)
CN (1) CN1142774C (de)
AT (1) ATE225168T1 (de)
AU (1) AU679467B2 (de)
CA (1) CA2109750A1 (de)
DE (1) DE69332350T2 (de)
DK (1) DK0600544T3 (de)
ES (1) ES2181682T3 (de)
IL (1) IL103920A (de)
MX (1) MX9307509A (de)
ZA (1) ZA938791B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262109B1 (en) 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
EP0793491B1 (de) * 1994-12-22 2003-05-02 Henkel Corporation Lycopen enthaltende pharmazeutische zusammensetzungen
JP2750281B2 (ja) * 1995-06-15 1998-05-13 睦憲 藤原 高コレステロール血症治療剤
IT1283143B1 (it) * 1996-07-12 1998-04-07 Indena Spa Metodo di estrazione del licopene ed estratti che lo contengono
US20060160702A1 (en) * 1998-02-23 2006-07-20 Etienne Soudant Compositions comprising anti-proliferative agents and use thereof
GB9808796D0 (en) 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
GB9821671D0 (en) 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
IL129442A0 (en) * 1999-04-14 2000-02-29 Lycored Natural Prod Ind Ltd Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood
US6482447B2 (en) 1999-09-10 2002-11-19 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
IL135335A (en) 2000-03-29 2013-12-31 Lycored Natural Prod Ind Ltd Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids
US6989161B2 (en) * 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
IL146449A0 (en) * 2001-11-12 2002-07-25 Lycored Natural Prod Ind Ltd Method and pharmaceutical preparations for reducing the activity of cells
EP1314438A1 (de) * 2001-11-23 2003-05-28 Nutricia N.V. Antiproliferative Zusammensetzung
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
WO2007043046A2 (en) 2005-10-11 2007-04-19 Lycored Ltd. Carotenoid oxidation products as chemopreventive and chemotherapeutic agents
US8569356B2 (en) * 2005-10-25 2013-10-29 University Of Florida Research Foundation, Inc. Cyclin dependent kinase inhibitors
TW200738227A (en) * 2006-04-03 2007-10-16 Panatoz Corp One kind of multi-carotenoids and its administration
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
CN101961354A (zh) * 2010-10-21 2011-02-02 蒋科罡 一种配用蜂王浆治疗肿瘤的中药及制法
CN101978986A (zh) * 2010-10-21 2011-02-23 蒋科罡 一种治疗肿瘤的中药制剂及制法
CN102894421A (zh) * 2011-07-24 2013-01-30 江西食方食坊中药食品有限公司 一种预防前列腺疾病的番杞饮料及其制备方法
CN107049998A (zh) * 2016-09-20 2017-08-18 南华大学附属第二医院 番茄红素顺式异构体在制备卵巢癌治疗药物中的应用
IT201700005649A1 (it) * 2017-01-19 2018-07-19 Associazione Oncologica Milanese Amo La Vita Onlus Uso di derivati di carotenoidi per ridurre la tossicità ed aumentare l’efficacia di trattamenti antitumorali anti-egfr
CN109172552A (zh) * 2018-07-18 2019-01-11 浙江格蕾斯生物科技有限公司 男性前列腺癌植物防治药物及制取方法
KR102220400B1 (ko) * 2019-03-06 2021-02-26 파이룽 머시너리 밀 코., 엘티디. 2개의 노크-오버로 형성된 비트 사이에 조절 가능한 간극을 갖는 횡편기 구조

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509587A (en) * 1975-08-19 1978-05-04 Ajinomoto Kk Anti-tumour composition
FR2558372B1 (fr) * 1984-01-25 1987-08-07 Oreal Composition medicamenteuse pour le traitement de l'acne
US5008295A (en) * 1987-07-30 1991-04-16 Lion Corporation Method inhibiting the growth of cancer cells
ES2073475T3 (es) * 1989-04-21 1995-08-16 Kirin Brewery Secuencias de dna utilizables en la sintesis de carotenoides.
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.

Also Published As

Publication number Publication date
DE69332350D1 (de) 2002-11-07
IL103920A (en) 2000-07-26
KR940011010A (ko) 1994-06-20
ZA938791B (en) 1994-10-03
MX9307509A (es) 1997-06-28
EP0600544B1 (de) 2002-10-02
CN1095589A (zh) 1994-11-30
DE69332350T2 (de) 2003-06-18
IL103920A0 (en) 1993-04-04
EP0600544A1 (de) 1994-06-08
AU679467B2 (en) 1997-07-03
KR100301682B1 (ko) 2001-10-22
CA2109750A1 (en) 1994-05-31
CN1142774C (zh) 2004-03-24
AU5201493A (en) 1994-06-09
US5827900A (en) 1998-10-27
ES2181682T3 (es) 2003-03-01
JPH06227970A (ja) 1994-08-16
DK0600544T3 (da) 2002-11-18

Similar Documents

Publication Publication Date Title
ATE225168T1 (de) Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen
ZA885192B (en) Pharmaceutical preparations
AU5094985A (en) Wound healing agents
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DE3031710C2 (de) Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen.
ES2194055T3 (es) Nuevo uso de prostaglandinas.
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
NO902104L (no) Kosmetisk blanding.
DE68916777T2 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
RU93053031A (ru) Способ снижения активности клеток, способ подавления раковых клеток и фармацевтические препараты для снижения активности клеток, способ лечения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties